Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial.

Barnadas, A

Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial. [electronic resource] - British journal of cancer Feb 2009 - 442-9 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1532-1827

10.1038/sj.bjc.6604868 doi


Aged
Aged, 80 and over
Androstadienes--therapeutic use
Antineoplastic Agents--therapeutic use
Aromatase Inhibitors--therapeutic use
Breast Neoplasms--drug therapy
Combined Modality Therapy
Disease Progression
Female
Humans
Middle Aged
Postmenopause
Receptors, Estrogen--metabolism
Survival Analysis